Comparison of ADVAIR medication vs Salmeterol vs Albuterol in Asthma patients, assessing lung function and other measures of asthma control.
Phase 1
- Conditions
- AsthmaTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
- Registration Number
- EUCTR2015-004865-10-Outside-EU/EEA
- Lead Sponsor
- GlaxoSmithKiline Research and Development LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- A
- Sex
- All
- Target Recruitment
- 547
Inclusion Criteria
Diagnosis of persistent asthma as define by the American Thoracic Society for at least 3 months prior to Visit 1.
Use of a short-acting beta-agonist medication like VENTOLIN.
Are the trial subjects under 18? yes
Number of subjects for this age range: 329
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 1819
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 63
Exclusion Criteria
Hospitalization for asthma 6 months before study
Other serious diseases like congestive heart failure, uncontrolled hypertension, TB.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method